의료기기 유통 서비스 시장 : 시장 기회, 성장요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Medical Device Distribution Services Market was valued at USD 51.7 billion in 2025 and is estimated to grow at a CAGR of 8.3% to reach USD 112.6 billion by 2035.

Market expansion is driven by the rising burden of chronic conditions, increasing investments in medical innovation, and a growing number of device approvals entering the healthcare ecosystem. Demand for advanced healthcare solutions, including remote monitoring and home-based care, is further accelerating the need for efficient distribution networks. Continuous progress in medical technology is increasing the volume and sophistication of devices, which in turn is intensifying reliance on specialized service providers. Growing financial support from public and private sectors is enabling faster development of diagnostic, therapeutic, and monitoring solutions, leading to a steady pipeline of new products. As the complexity of supply chains increases, distribution partners are becoming essential in managing compliance requirements, logistics operations, and inventory systems. Their role in bridging manufacturers and healthcare providers continues to strengthen, supporting consistent product availability and driving sustained global market growth.

The therapeutic devices segment generated USD 15.3 billion in 2025. This segment encompasses a wide range of technologies designed for treatment, long-term care, and functional support across healthcare systems. These devices are extensively utilized in various care settings and are critical for both immediate interventions and ongoing disease management. The distribution of such products involves highly structured supply chain processes due to strict handling requirements and regulatory oversight. A large proportion of these devices falls under higher regulatory classifications, which demand rigorous compliance standards. As a result, distribution service providers play a vital role in ensuring proper storage, transportation, and delivery while maintaining adherence to quality and safety protocols.

The hospitals and clinics segment accounted for USD 31.2 billion in 2025. Healthcare facilities rely heavily on distribution services to maintain uninterrupted access to essential medical equipment, enabling efficient care delivery and timely clinical decisions. Increasing patient volumes and the transition toward outcome-focused care models are amplifying the need for reliable supply chain support. Distribution providers contribute significantly by ensuring consistent product availability and optimizing logistics operations within healthcare environments, which is critical for maintaining efficiency and continuity in patient care services.

U.S. Medical Device Distribution Services Market reached USD 18.6 billion in 2025 supported by strong healthcare expenditure and widespread adoption of advanced medical technologies. The growing prevalence of chronic health conditions is further driving demand for efficient distribution networks. Additionally, stringent regulatory requirements and the complexity of healthcare systems are increasing the need for specialized service providers that can manage compliance, inventory, and timely delivery, ensuring operational efficiency and uninterrupted patient care.

Key players operating in the Global Medical Device Distribution Services Market include McKesson Corporation, Cardinal Health, Owens & Minor, Medline, Henry Schein, Patterson Companies, Bunzl, Avantor, Alfresa Holdings Corporation, KEBOMED Europe, CAN-med Healthcare, Meditek Systems, Soquelec, Southmedic, and The Stevens Company Limited. Companies in the Medical Device Distribution Services Market are strengthening their market position through strategic investments in technology, infrastructure, and partnerships. Businesses are focusing on enhancing supply chain efficiency by adopting digital tools, automation, and advanced inventory management systems. Collaborations with manufacturers and healthcare providers are helping expand distribution networks and improve service capabilities. Firms are also investing in compliance frameworks to meet stringent regulatory standards and ensure safe handling of medical devices. Geographic expansion into emerging markets is another key strategy to capture new growth opportunities.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation for any one approach
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
  • 2.1.1 Key market trends
  • 2.1.2 Product trends
  • 2.1.3 End use trends
  • 2.1.4 Regional trends
• 2.2 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of chronic diseases
    • 3.2.1.2 Surge in investments for research and growth in medical device approvals
    • 3.2.1.3 Rising demand for home healthcare and remote monitoring
    • 3.2.1.4 Advancements in medical device technology
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Requirement for high initial capital expenditure
    • 3.2.2.2 Presence of stringent regulatory compliance
  • 3.2.3 Market opportunity
    • 3.2.3.1 Growth in online distribution services and digital ordering system
    • 3.2.3.2 Increasing public private partnership to strengthen supply chain
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape (Driven by Primary Research)
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technological landscape (Driven by Primary Research)
  • 3.5.1 Current technologies
    • 3.5.1.1 Artificial intelligence (AI) and automation in supply chain
    • 3.5.1.2 Internet of things (IoT) for real-time tracking
    • 3.5.1.3 Digital twins for supply chain simulation
  • 3.5.2 Emerging technologies
    • 3.5.2.1 5G-enabled logistics and remote monitoring
    • 3.5.2.2 Autonomous delivery systems
• 3.6 Future market trends (Driven by Primary Research)
• 3.7 Pricing analysis, 2025 (Driven by Primary Research)
• 3.8 Patent analysis (Driven by Primary Research)
• 3.9 Impact of AI and Generative AI on the market (Driven by Primary Research)
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Merger and acquisition
  • 4.6.2 Partnership and collaboration
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Diagnostic devices
• 5.3 Therapeutic devices
• 5.4 Patient monitoring devices
• 5.5 Home healthcare devices
• 5.6 Other device distribution services

Chapter 6 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals and clinics
• 6.3 Diagnostic centers
• 6.4 Ambulatory surgical centers (ASCs)
• 6.5 Long-term care facilities
• 6.6 Homecare settings

Chapter 7 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 Alfresa Holdings Corporation
• 8.2 Avantor
• 8.3 Bunzl
• 8.4 CAN-med Healthcare
• 8.5 Cardinal Health
• 8.6 Henry Schein
• 8.7 KEBOMED Europe
• 8.8 McKesson Corporation
• 8.9 Meditek Systems
• 8.10 Medline
• 8.11 Owens & Minor
• 8.12 Patterson Companies
• 8.13 Soquelec
• 8.14 Southmedic
• 8.15 The Stevens Company Limited